ECO Animal Health Group plc announced that the Committee for Medicinal Products for Veterinary Use of the European Medicines Agency has adopted a Positive Opinion recommending the granting of EU marketing authorisation for ECOVAXXIN MS, a poultry vaccine against Mycoplasma synoviae.
Based on the Positive Opinion, the EMA is expected to issue a marketing authorisation during the first quarter of 2026. ECO Animal Health expects making ECOVAXXIN MS commercially available in the European Union in the second half of 2026.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.